eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
3/2003
vol. 7
 
Share:
Share:
more
 
 
abstract:

The role of chemotherapy in prostate cancer

Katarzyna Sosińska-Mielcarek
,
Elżbieta Senkus-Konefka

Online publish date: 2003/05/12
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Although endocrine therapy remains the main method of systemic treatment in prostate cancer, there is an increasing interest in the use of chemotherapy. For many years prostate cancer has been considered a chemoresistant tumour. However, the introduction of novel drugs and new combination regimens have resulted in a considerable progress in treatment outcomes. The most commonly used agent in prostate cancer is estramustine, a combination of estrogen with nitrogen mustard. Estramustine has been combined with antitubuline agents such as vinblastine, paclitaxel or docetaxel. Currently, one of the most common regimens is the combination of mitoxantrone and prednisone. In clinical trials chemotherapy has been typically used in patients progressing while being on endocrine therapy. In these patients, the response rate approached 50%. However, to date chemotherapy has not been demonstrated to increase survival in prostate cancer and the major benefit has been an improvement of quality of life. Currently, there are several ongoing phase III clinical trials comparing new versus standard regimens. Other clinical trials are investigating the role of chemotherapy as an adjunct to local modalities in poor-risk locally advanced prostate cancer. Enrollment of patients into properly designed clinical trials of new cytotoxic agents and combination regimens is warranted to better delineate the role of chemotherapy in the management of prostate cancer.
keywords:

prostate cancer, chemotherapy, adjuvant treatment, palliative treatment

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe